Clik here to view.
What’s next in line for fatty liver disease? – NASH News
Madrigal Pharmaceuticals Announces EMA Validation of its Marketing Authorization Application for Resmetirom for the Treatment of NASH/MASH with Liver Fibrosis Madrigal Pharmaceuticals celebrates...
View ArticleClik here to view.
FDA’s Approval of Breakthrough NASH Treatment Opens Door for a Long-Neglected...
FDA’s Approval of Breakthrough NASH Treatment Opens Door for a Long-Neglected Patient Population GLI Celebrates Approval of Madrigal Pharmaceutical’s Rezdiffra™ (resmetirom) as Milestone for Liver...
View ArticleClik here to view.
GLI Commends Repurposed Livmarli’s FDA Approval for Patients over 5 with PFIC
GLI Commends Repurposed Livmarli’s FDA Approval for Patients over 5 with PFIC (Washington, D.C. March 14, 2024) –Global Liver Institute (GLI) celebrates a win for rare disease patients with the...
View ArticleClik here to view.
7th Annual Global Fatty Liver Day is less than 3 months away!
7th Annual Global Fatty Liver Day, formerly known as International NASH Day, is less than 3 months away! Fatty liver disease is a widespread issue that often goes undetected until it’s too late. It...
View ArticleClik here to view.
Media Kit: Preparing for First US Approval of NASH Therapy
GLI Commends Repurposed Livmarli’s FDA Approval for Patients over 5 with PFIC (Washington, D.C. March 14, 2024) –Global Liver Institute (GLI) celebrates a win for rare disease patients with the...
View ArticleClik here to view.
Healthy Eating, Healthy Liver: The Links Between Nutrition and Liver Wellness
Healthy Eating, Healthy Liver: The Links Between Nutrition and Liver Wellness Maintaining optimal liver health is crucial, given the liver’s pivotal role as a major detoxifying organ. The liver,...
View ArticleClik here to view.
NIH Launches Research Network To Evaluate Emerging Cancer Screening...
White House declares April 2024 as Cancer Prevention and Early Detection Month This landmark announcement from the White House follows ongoing advocacy efforts, including a letter to President Joe...
View ArticleClik here to view.
GLI Celebrates US Treatment for NASH as Milestone for Liver Health – NASH News
The U.S. FDA approves Madrigal Pharmaceuticals Rezdiffra™ (resmetirom) as the FIRST NASH therapeutic option in the U.S. This breakthrough follows years of NASH patient-led multi-stakeholder...
View ArticleClik here to view.
Celebrating the benefits of drug repurposing for pediatric rare liver disease...
Celebrating the repurposed use of Livmarli for pediatric rare liver disease patients Global Liver Institute (GLI) celebrates a major breakthrough with the U.S. FDA’s approval for Mirum...
View ArticleClik here to view.
Congress begins Fiscal Year 2025 appropriations process and the...
Congress begins Fiscal Year 2025 appropriations process and the Administration approves new treatments improving the lives of liver disease patients. Congress finalizes last remaining FY 2024 spending...
View ArticleClik here to view.
Addressing Disparities in Organ Transplantation: A Call for Equitable Healthcare
Addressing Disparities in Organ Transplantation: A Call for Equitable Healthcare Introduction Organ transplantation has revolutionized modern medicine, offering a beacon of hope for individuals...
View ArticleGlobal Liver Institute Statement on the Passing of Dr. Stephen Harrison
Global Liver Institute Statement on the Passing of Dr. Stephen Harrison The entire field of liver health has experienced an incredible loss. It is with great sadness that Global Liver Institute, our...
View ArticleClik here to view.
Early-onset cancer rates rates are increasing globally – Liver Cancer News
We extend our deepest gratitude to Dr. Jennifer Guy, Dr. Anjana Pillai, Dr. Christopher Rose, Dr. Elliot Tapper, patient advocate Bruce Dimming, and our sponsors. In case you missed it, our webinar...
View ArticleClik here to view.
Global Liver Institute Thanks Senator Bill Cassidy for His Leadership in...
Global Liver Institute Thanks Senator Bill Cassidy for His Leadership in Fatty Liver Disease Research U.S. Agency for Healthcare Research and Quality to Assess True Prevalence and Impact of...
View ArticleClik here to view.
How does sleep affect fatty liver disease? – NASH News
Providing Access to Rezdiffra for NASH and the Therapies to Come | AMCP 2024 At the Academy of Managed Care Pharmacy meeting on April 16, experts discussed the emerging landscape of NASH treatments,...
View ArticleClik here to view.
A Spotlight on Rare Maternal Health – Pediatric & Rare Liver Diseases News
Upcoming Pediatric and Rare Liver Diseases Council Semi-Annual Meeting Our upcoming council meeting is scheduled for May 8, 2024. We’re thrilled to welcome Alex Betourne, PhD, PharmD, the...
View ArticleClik here to view.
A3 Builds Support for Liver Health Policy Priorities – Liver Health Policy...
Congress begins Fiscal Year 2025 appropriations process and the Administration approves new treatments improving the lives of liver disease patients. In the post-election work period, “must-do”...
View ArticleExploring Viral Hepatitis: Types, Diagnosis, and Treatment
Exploring Viral Hepatitis: Types, Diagnosis, and Treatment Viral hepatitis, a group of infections affecting the liver, has long been a global health concern. As the seventh leading cause of death...
View ArticleClik here to view.
Global Leaders Gather to Exchange Best Practices in Liver Health Policy
Global Leaders Gather to Exchange Best Practices in Liver Health Policy Global Liver Institute Convenes Fruitful Meeting on the Sidelines of WHA77 (Geneva, Switzerland, May 29, 2024) – Global Liver...
View ArticleClik here to view.
The Build-Up to Global Fatty Liver Day – Fatty Liver Disease News
June 13 is Global Fatty Liver Day June 13 marks Global Fatty Liver Day, and the time to act is NOW! With conditions like obesity and diabetes increasing the risk for fatty liver disease, early...
View Article